The subjective and objective very long-term outcomes of TVT in the COVID era: A 20-year follow-up.
Andrea BragaGiorgio CacciaAndrea PapadiaFabiana CastronovoStefano SalvatoreChiara ScancarelloMarco TorellaFabio GhezziMaurizio SeratiPublished in: International urogynecology journal (2022)
The 20-year results of this study showed that TVT is a highly effective and safe option for the treatment of SUI. The impact of COVID 19 on the mortality rate of elderly women has drastically reduced the number of eligible patients for future evaluations in our region.
Keyphrases
- coronavirus disease
- sars cov
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- polycystic ovary syndrome
- risk factors
- current status
- metabolic syndrome
- cardiovascular disease
- patient reported outcomes
- sleep quality
- pregnancy outcomes
- insulin resistance
- coronary artery disease
- replacement therapy
- cervical cancer screening